Nothing Special   »   [go: up one dir, main page]

Torzillo et al., 1999 - Google Patents

Etiology of acute lower respiratory tract infection in Central Australian Aboriginal children

Torzillo et al., 1999

Document ID
7187382277434264862
Author
Torzillo P
Dixon J
Manning K
Hutton S
Gratten M
Hueston L
Leinonen M
Morey F
Forsythe S
Num R
Erlich J
Asche V
Cunningham A
Riley I
Publication year
Publication venue
The Pediatric infectious disease journal

External Links

Snippet

Background. Aboriginal children in central Australia have attack rates for acute lower respiratory tract infection (ALRI) that are similar to those in developing countries. Although mortality rates are much lower than in developing countries, morbidity is high and ALRI is …
Continue reading at journals.lww.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56916—Enterobacteria, e.g. shigella, salmonella, klebsiella, serratia
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/24—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia

Similar Documents

Publication Publication Date Title
Torzillo et al. Etiology of acute lower respiratory tract infection in Central Australian Aboriginal children
Grayston et al. A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections
Harrison et al. Chlamydia trachomatis infant pneumonitis: comparison with matched controls and other infant pneumonitis
Szelc-Kelly et al. Serologic responses to Bartonella and Afipia antigens in patients with cat scratch disease
Mulholland et al. Etiology of serious infections in young Gambian infants
O'DEMPSEY et al. Pneumococcal disease among children in a rural area of west Africa
Wubbel et al. Etiology and treatment of community-acquired pneumonia in ambulatory children
Holmes et al. Etiology of nongonococcal urethritis
Harris et al. Safety and efficacy of azithromycin in the treatment of community-acquired pneumonia in children
Lieberman et al. Pneumonia with serological evidence of acute infection with the Chlamydia-like microorganism “Z”
Darville Chlamydia trachomatis infections in neonates and young children
Lin et al. Level of maternal antibody required to protect neonates against early-onset disease caused by group B Streptococcus type Ia: a multicenter, seroepidemiology study
Hewlett et al. Pertussis—not just for kids
Meuwissen et al. Parasitologic and serologic observations of infection with Pneumocystis in humans
Winston et al. Ganciclovir prophylaxis of cytomegalovirus infection and disease in allogeneic bone marrow transplant recipients: results of a placebo-controlled, double-blind trial
Baer et al. Role of Chlamydia pneumoniae and Mycoplasma pneumoniae as causative agents of community-acquired pneumonia in hospitalised children and adolescents
FALCK et al. Prevalence of Chlamydia pneumoniae in healthy children and in children with respiratory tract infections
Leineweber et al. Transplacentally acquired immunoglobulin G antibodies against measles, mumps, rubella and varicella-zoster virus in preterm and full term newborns
Brahmbhatt et al. Association of HIV and malaria with mother-to-child transmission, birth outcomes, and child mortality
Rae et al. Chlamydial serologic studies and recurrent spontaneous abortion
Norden et al. Haemophilus influenzae meningitis in an adult: A study of bactericidal antibodies and immunoglobulins
Davis et al. Update on protozoan parasites of the intestine
Quinn et al. Screening for Chlamydia trachomatis infection in an inner-city population: a comparison of diagnostic methods
Piedra et al. Sequential annual administration of purified fusion protein vaccine against respiratory syncytial virus in children with cystic fibrosis
Ben-Shimol et al. Post–13-Valent Pneumococcal Conjugate Vaccine Dynamics in Young Children of Serotypes Included in Candidate Extended-Spectrum Conjugate Vaccines